AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 286: R1013-R1023, 2004; doi:10.1152/ajpregu.00729.2003
0363-6119/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orshal, J. M.
Right arrow Articles by Khalil, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orshal, J. M.
Right arrow Articles by Khalil, R. A.

NEUROHUMORAL CONTROL OF CIRCULATION AND HYPERTENSION

Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats

Julia M. Orshal and Raouf A. Khalil

Department of Medicine, Veterans Affairs Medical Center, West Roxbury 02132; and Harvard Medical School, Boston, Massachusetts 02132

Submitted 24 December 2003 ; accepted in final form 19 January 2004

IL-6 is elevated in plasma of preeclamptic women, and twofold elevation of plasma IL-6 increases vascular resistance and arterial pressure in pregnant rats, suggesting a role of the cytokine in hypertension of pregnancy. However, whether the hemodynamic effects of IL-6 reflect direct effects of the cytokine on the mechanisms of vascular contraction/relaxation is unclear. The purpose of this study was to test the hypothesis that IL-6 directly impairs endothelium-dependent relaxation and enhances vascular contraction in systemic vessels of pregnant rats. Active stress was measured in aortic strips isolated from virgin and late pregnant Sprague-Dawley rats and then nontreated or treated for 1 h with IL-6 (10 pg/ml to 10 ng/ml). In endothelium-intact vascular strips, phenylephrine (Phe, 10–5 M) caused an increase in active stress that was smaller in pregnant (4.2 ± 0.3) than virgin rats (5.1 ± 0.3 x 104 N/m2). IL-6 (1,000 pg/ml) caused enhancement of Phe contraction that was greater in pregnant (10.6 ± 0.7) than virgin rats (7.5 ± 0.4 x 104 N/m2). ACh and bradykinin caused relaxation of Phe contraction and increases in vascular nitrite production that were greater in pregnant than virgin rats. IL-6 caused reductions in ACh- and bradykinin-induced vascular relaxation and nitrite production that were more prominent in pregnant than virgin rats. Incubation of endothelium-intact strips in the presence of N{omega}-nitro-L-arginine methyl ester (10–4 M) to inhibit nitric oxide (NO) synthase, or 1H-[1,2,4]oxadiazolo[4,3]-quinoxalin-1-one (ODQ, 10–5 M) to inhibit cGMP production in smooth muscle, inhibited ACh-induced relaxation and enhanced Phe-induced stress in nontreated but to a lesser extent in IL-6-treated vessels, particularly those of pregnant rats. Removal of the endothelium enhanced Phe-induced stress in nontreated but not IL-6-treated vessels, particularly those of pregnant rats. In endothelium-denuded strips, relaxation of Phe contraction with sodium nitroprusside, an exogenous NO donor, was not different between nontreated and IL-6-treated vessels of virgin or pregnant rats. Thus IL-6 inhibits endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of virgin and pregnant rats. The greater IL-6-induced inhibition of vascular relaxation and enhancement of contraction in systemic vessels of pregnant rats supports a direct role for IL-6 as one possible mediator of the increased vascular resistance associated with hypertension of pregnancy.

cytokines; nitric oxide; pregnancy



Address for reprint requests and other correspondence: R. A. Khalil, Harvard Medical School, VA Boston Healthcare-Research, 1400 VFW Parkway, 3/2B123, Boston, MA 02132 (E-mail: raouf_khalil{at}hms.harvard.edu).




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Martinez-Revelles, F. Jimenez-Altayo, L. Caracuel, F. J. Perez-Asensio, A. M. Planas, and E. Vila
Endothelial Dysfunction in Rat Mesenteric Resistance Artery after Transient Middle Cerebral Artery Occlusion
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 363 - 369.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. I. Schrader, D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion
IL-6 Deficiency Protects Against Angiotensin II Induced Endothelial Dysfunction and Hypertrophy
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2576 - 2581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. I. Boesen and D. M. Pollock
Effect of chronic IL-6 infusion on acute pressor responses to vasoconstrictors in mice
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1745 - H1749.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. L. Lee, L. C. Sturgis, H. Labazi, J. B. Osborne Jr., C. Fleming, J. S. Pollock, M. Manhiani, J. D. Imig, and M. W. Brands
Angiotensin II hypertension is attenuated in interleukin-6 knockout mice
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H935 - H940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Granger
Inflammatory cytokines, vascular function, and hypertension
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R989 - R990.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.